Bilateral Closed Loop Deep Brain Stimulation for Freezing of Gait using Neural and Kinematic Feedback
利用神经和运动学反馈进行双边闭环深部脑刺激以冻结步态
基本信息
- 批准号:10670150
- 负责人:
- 金额:$ 120.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:Adverse effectsAffectAgeAlgorithmsBehavior ControlBehavioralBilateralBluetoothBradykinesiaBrainCessation of lifeClinical ResearchComplicationDataDeep Brain StimulationDevelopmentDevice or Instrument DevelopmentDevicesDisease ProgressionDoseEmerging TechnologiesEnvironmentFamilyFeedbackFreezingFrequenciesFutureGaitGluesHomeHome environmentImpairmentImplantIncidenceIndependent LivingIndustry CollaborationInjuryInstitutionLeadLegLewy Body DementiaLocomotionMeasurementMeasuresMotorMovement Disorder Society Unified Parkinson&aposs Disease Rating ScaleNational Institute of Neurological Disorders and StrokeNeurodegenerative DisordersOutcomeParkinson DiseasePatientsPeriodicityPersonsPharmaceutical PreparationsPoliciesPopulationProgressive Supranuclear PalsyResearchResearch PrioritySafetySignal TransductionSocietiesStructure of subthalamic nucleusSystemTechnologyTestingTimeTranslatingTremorWalkingarmbench to bedsidecohortdesigndisabilityeffective therapyexperienceexperimental studyfallsfeasibility testingfoothome testimprovedkinematicsmotor disordermotor symptomnervous system disorderneuralneuroregulationnext generationnovelpartial responseparticipant safetypatient safetypreventprimary outcomeresponsesafety and feasibilitysafety testingsecondary outcomesensorside effectsymposiumwearable sensor technology
项目摘要
Gait impairment and Freezing of gait (FOG), lead to falls, injury (even death), loss of independent living, and are
common in neurodegenerative diseases such as Parkinson’s Disease (PD), affecting over 7 million people
worldwide. The incidence of neurodegenerative diseases increases with age and as the population lives longer,
the societal consequences of FOG, will be very significant. Gait impairment and FOG have a partial response to
medication and subthalamic nucleus (STN) open loop deep brain stimulation (olDBS), which cannot adjust
therapy in response to underlying brain signals or motor symptoms such as FOG. One reason is that FOG may
respond to different parameters of DBS, such as lower frequency, than that needed for tremor and most patients
do not tolerate 60 Hz DBS for long periods of time. Emerging technology using sensing neurostimulators and
Bluetooth enabled wearable sensors has allowed research into closed loop or adaptive (a)DBS using neural or
behavioral control variables. FOG is episodic and usually occurs in predictable environments, so it is well suited
for ‘on demand’ aDBS. ADBS, responding to markers of gait impairment and intermittent FOG, with changes in
DBS intensity or frequency, could then prevent FOG, falls and injury, while still treating other motor signs of PD.
From over four years of research and regulatory experience in an academic-industry collaboration with
Medtronic, we have provided design inputs for the next generation aDBS devices, and have determined that
aDBS for tremor and bradykinesia is safe and tolerable in the largest freely-moving PD cohort implanted with a
Medtronic investigative neurostimulation/sensing system (Activa® PC+S-Nexus D/D3/E). We have discovered
neural and behavioral markers of gait impairment and FOG using synchronized neural and kinematic recordings
during gait tasks that elicit FOG. Our research findings and the technological advances embedded in the
Medtronic Summit® RC+S-system now enable the next step: the first clinical studies of lateralized, independent,
bilateral STN aDBS control algorithms for FOG in PD, driven by subject-specific neural (Aim 1) or behavioral
(Aim 2) control variables, and in response to medication (Aim 3). The project will translate stepwise in a ‘bench
to bedside’ manner, testing aDBS during the stepping in place (SIP) task, where the subject is in a harness and
steps in place on dual force-plates. Then aDBS will be tested during the forward walking Turning and Barrier
Course, which mimics environments known to trigger FOG in the real world, and then how aDBS responds to
subject-specific doses of medication, while freely moving. The outcome of these experiments will provide critical
next-steps for safety and feasibility of testing aDBS for gait impairment and FOG in the subject’s home
environment, and on their normal medication. Patient safety, tolerability, adverse effects, gait parameters, and
the number and duration of freezing episodes (FEs), during no DBS, olDBS, aDBS and a control, intermittent
(i)olDBS will provide inputs for future devices and novel algorithms applicable to NaDBS or KaDBS for gait
impairment and FOG in other neurological diseases.
步态障碍和冻结步态(雾),导致跌倒,受伤(甚至死亡),失去独立生活,是
在帕金森氏病(PD)等神经退行性疾病中常见,影响了700万人
全世界。神经退行性疾病的事件随着年龄的增长而增加,随着人口的寿命更长,
雾的社会后果将非常重要。步态障碍和雾对
药物和丘脑下核(STN)开环深脑刺激(OldBS),无法调整
响应潜在的脑信号或运动症状(例如雾)的治疗。一个原因是雾可能
响应与震颤和大多数患者所需的DBS不同参数(例如较低的频率)
长时间不要忍受60 Hz DBS。使用传感神经刺激器和
启用蓝牙的可穿戴传感器已使使用神经或自适应的闭环或自适应(a)DBS进行研究
行为控制变量。雾是情节性的,通常发生在可预测的环境中,因此非常适合
用于“按需” ADB。 ADB,响应搅拌和间歇性雾的标记,随着变化的变化
DBS强度或频率可以防止雾,跌落和受伤,同时仍处理其他电动机迹象。
从与学术行业合作的四年来研究和监管经验
Medtronic,我们为下一代ADB设备提供了设计输入,并确定
在最大的自由移动的PD队列中,震颤和颤音的ADB是安全可容忍的
Medtronic研究神经刺激/传感系统(Activa®PC+S-Nexus D/D3/E)。我们发现了
使用同步神经和运动学记录的搅动和雾的神经和行为标记
在引起雾气的步态任务中。我们的研究发现以及嵌入的技术进步
MedtronicSummit®RC+S-System现在启用下一步:侧向,独立的临床研究
由主体特异性神经(AIM 1)或行为驱动的PD中的双侧STN ADBS控制算法
(AIM 2)控制变量,并响应药物治疗(AIM 3)。该项目将在“长凳上逐步翻译”
床边的方式,在踏入到位期间测试ADB(sip)任务,该主题处于安全带中,
在双力平板上逐步踩踏。然后在前进的转弯和障碍期间测试ADB
当然,哪些模仿了在现实世界中触发雾的已知环境,然后ADB如何回应
特定于主体的药物剂量,同时自由移动。这些实验的结果将提供关键
下一步的安全性和测试ADB在受试者家中进行搅动和雾气的可行性
环境及其正常药物。患者的安全性,耐受性,不良影响,收集参数和
冻结剧集(FES)的数量和持续时间,在没有DBS,OldBS,ADB和控制期间,间歇性
(i)OldBS将为未来的设备和适用于NADBS或KADBS的新算法提供输入
其他神经疾病中的损害和雾气。
项目成果
期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ramp Rate Evaluation and Configuration for Safe and Tolerable Closed-Loop Deep Brain Stimulation.
- DOI:10.1109/ner49283.2021.9441336
- 发表时间:2021-05
- 期刊:
- 影响因子:0
- 作者:Petrucci, Matthew N.;Wilkins, Kevin B.;Orthlieb, Gerrit C.;Kehnemouyi, Yasmine M.;O'Day, Johanna J.;Herron, Jeffrey A.;Bronte-Stewart, Helen M.
- 通讯作者:Bronte-Stewart, Helen M.
Demonstration of Kinematic-Based Closed-loop Deep Brain Stimulation for Mitigating Freezing of Gait in People with Parkinson's Disease.
- DOI:10.1109/embc44109.2020.9176638
- 发表时间:2020-07
- 期刊:
- 影响因子:0
- 作者:O'Day JJ;Kehnemouyi YM;Petrucci MN;Anderson RW;Herron JA;Bronte-Stewart HM
- 通讯作者:Bronte-Stewart HM
A Closed-loop Deep Brain Stimulation Approach for Mitigating Burst Durations in People with Parkinson's Disease.
- DOI:10.1109/embc44109.2020.9176196
- 发表时间:2020-07
- 期刊:
- 影响因子:0
- 作者:Petrucci MN;Anderson RW;O'Day JJ;Kehnemouyi YM;Herron JA;Bronte-Stewart HM
- 通讯作者:Bronte-Stewart HM
A validated measure of rigidity in Parkinson's disease using alternating finger tapping on an engineered keyboard.
- DOI:10.1016/j.parkreldis.2020.10.047
- 发表时间:2020-12
- 期刊:
- 影响因子:4.1
- 作者:Trager MH;Wilkins KB;Koop MM;Bronte-Stewart H
- 通讯作者:Bronte-Stewart H
Differential Effects of Pathological Beta Burst Dynamics Between Parkinson's Disease Phenotypes Across Different Movements.
- DOI:10.3389/fnins.2021.733203
- 发表时间:2021
- 期刊:
- 影响因子:4.3
- 作者:Neuville RS;Petrucci MN;Wilkins KB;Anderson RW;Hoffman SL;Parker JE;Velisar A;Bronte-Stewart HM
- 通讯作者:Bronte-Stewart HM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Helen Bronte-Stewart其他文献
Helen Bronte-Stewart的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Helen Bronte-Stewart', 18)}}的其他基金
Neurostimulation of the Nucleus Basalis of Meynert for the cognitive-motor syndrome in Parkinson's disease
梅纳特基底核神经刺激治疗帕金森病认知运动综合征
- 批准号:
10686249 - 财政年份:2022
- 资助金额:
$ 120.97万 - 项目类别:
Neurostimulation of the Nucleus Basalis of Meynert for the cognitive-motor syndrome in Parkinson's disease
梅纳特基底核神经刺激治疗帕金森病认知运动综合征
- 批准号:
10510424 - 财政年份:2022
- 资助金额:
$ 120.97万 - 项目类别:
Bilateral Closed Loop Deep Brain Stimulation for Freezing of Gait using Neural and Kinematic Feedback
利用神经和运动学反馈进行双边闭环深部脑刺激以冻结步态
- 批准号:
10218278 - 财政年份:2019
- 资助金额:
$ 120.97万 - 项目类别:
Bilateral Closed Loop Deep Brain Stimulation for Freezing of Gait using Neural and Kinematic Feedback
利用神经和运动学反馈进行双边闭环深部脑刺激以冻结步态
- 批准号:
10455532 - 财政年份:2019
- 资助金额:
$ 120.97万 - 项目类别:
Neural and Kinematic Features of Freezing of Gait for Adaptive Neurostimulation
自适应神经刺激步态冻结的神经和运动学特征
- 批准号:
9360002 - 财政年份:2016
- 资助金额:
$ 120.97万 - 项目类别:
THE DURATION OF THERAPEUTIC EFFECT OF DEEP BRAIN STIMULATION PARKINSON'S
脑深部刺激帕金森病治疗效果的持续时间
- 批准号:
7605170 - 财政年份:2007
- 资助金额:
$ 120.97万 - 项目类别:
THE DURATION OF THERAPEUTIC EFFECT OF DEEP BRAIN STIMULATION PARKINSON'S DISEASE
脑深部刺激帕金森病治疗效果的持续时间
- 批准号:
7375206 - 财政年份:2005
- 资助金额:
$ 120.97万 - 项目类别:
THE DURATION OF THERAPEUTIC EFFECT OF DEEP BRAIN STIMULATION PARKINSON'S DISEASE
脑深部刺激帕金森病治疗效果的持续时间
- 批准号:
7202041 - 财政年份:2004
- 资助金额:
$ 120.97万 - 项目类别:
Duration of therapeutic effect of deep brain stimulation
脑深部刺激治疗效果的持续时间
- 批准号:
6980924 - 财政年份:2003
- 资助金额:
$ 120.97万 - 项目类别:
相似国自然基金
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
恒星模型中氧元素丰度的变化对大样本F、G、K矮星年龄测定的影响
- 批准号:12303035
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于年龄和空间的非随机混合对性传播感染影响的建模与研究
- 批准号:12301629
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
母传抗体水平和疫苗初种年龄对儿童麻疹特异性抗体动态变化的影响
- 批准号:82304205
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
中国东部地区大气颗粒物的年龄分布特征及其影响因素的模拟研究
- 批准号:42305193
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
- 批准号:
10751106 - 财政年份:2024
- 资助金额:
$ 120.97万 - 项目类别:
Maternal inflammation in relation to offspring epigenetic aging and neurodevelopment
与后代表观遗传衰老和神经发育相关的母体炎症
- 批准号:
10637981 - 财政年份:2023
- 资助金额:
$ 120.97万 - 项目类别:
Impact of Body Composition and Related Inflammatory and Immune States on Prognosis of Non-Muscle Invasive Bladder Cancer
身体成分及相关炎症和免疫状态对非肌肉浸润性膀胱癌预后的影响
- 批准号:
10674401 - 财政年份:2023
- 资助金额:
$ 120.97万 - 项目类别:
The Role of Outpatient Diuretic Therapy in Bronchopulmonary Dysplasia
门诊利尿疗法在支气管肺发育不良中的作用
- 批准号:
10663469 - 财政年份:2023
- 资助金额:
$ 120.97万 - 项目类别:
Preclinical testing of early life anti-myostatin therapy for osteogenesis imperfecta
早期抗肌生长抑制素治疗成骨不全症的临床前测试
- 批准号:
10840238 - 财政年份:2023
- 资助金额:
$ 120.97万 - 项目类别: